SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-021031
Filing Date
2020-08-10
Accepted
2020-08-10 08:00:14
Documents
2
Period of Report
2020-08-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea125247-6k_kamadaltd.htm 6-K 17539
2 KAMADA ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS PHASE 1/2 CLINICAL TRIAL OF ea125247ex99-1_kamadaltd.htm EX-99.1 18740
  Complete submission text file 0001213900-20-021031.txt   37256
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 201087166
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences